Chemclin Diagnostics Co. Ltd. A Cash Flow-to-Debt Ratio
Chemclin Diagnostics Co. Ltd. A cash flow-to-debt ratio. Chemclin Diagnostics Co. Ltd. A (688468) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥34.41 Million could theoretically repay 0% of its total liabilities (CN¥363.17 Million) in one year. Check Chemclin Diagnostics Co. Ltd. A (688468) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chemclin Diagnostics Co. Ltd. A (2017–2025)
Cash flow-to-debt ratio of Chemclin Diagnostics Co. Ltd. A from 2017 to 2025. Historical debt coverage capacity for Chemclin Diagnostics Co. Ltd. A across 9 annual periods. Check Chemclin Diagnostics Co. Ltd. A (688468) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Chemclin Diagnostics Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2017–2025)
Chemclin Diagnostics Co. Ltd. A cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Chemclin Diagnostics Co. Ltd. A. For the full cash flow conversion analysis, see Chemclin Diagnostics Co. Ltd. A (688468) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | CN¥93.90 Million | CN¥350.05 Million | ▼ -33.6% |
| 2024 | 0.40x | CN¥167.95 Million | CN¥415.85 Million | ▲ +0.8% |
| 2023 | 0.40x | CN¥173.05 Million | CN¥431.76 Million | ▼ -65.5% |
| 2022 | 1.16x | CN¥244.56 Million | CN¥210.59 Million | ▼ -6.4% |
| 2021 | 1.24x | CN¥188.86 Million | CN¥152.23 Million | ▼ -2.5% |
| 2020 | 1.27x | CN¥151.95 Million | CN¥119.46 Million | ▼ -20.1% |
| 2019 | 1.59x | CN¥201.27 Million | CN¥126.42 Million | ▼ -12.8% |
| 2018 | 1.83x | CN¥147.68 Million | CN¥80.87 Million | ▼ -9.5% |
| 2017 | 2.02x | CN¥133.46 Million | CN¥66.15 Million | — |